The Malek Lab at the University of Miami Miller School of Medicine is recruiting Postdoctoral fellows to study the cellular and molecular mechanisms contributing to regulatory T cell-based immunotherapy of autoimmune diseases, with a focus on type 1 diabetes. Current projects offer the opportunity to participate in highly translational and collaborative effort aimed at re-regulating immune respon ses to restore tolerance by selectively boosting regulatory T cells through the application of limiting amounts of IL-2 or novel IL-2 analogs with improved pharmacology. Our efforts encompass mechanistic studies on how low dose IL-2 acts on human Treg and T effector cells. Underpinning this effort is a new phase 2 multi-center clinical trial in type 1 diabetes organized at the University of Miami. Mouse models are also used to further define the activity of such pathways in vivo.
The minimum qualifications for this position are as follows: Prior experience in immunology, including mouse models of autoimmune disease, human immunology, flow cytometry, tissue imaging and/or in molecular biology and bioinformatics is preferred. Highly motivated individuals with a recent Ph.D., a strong track record of research as evidenced by publications in pee r reviewed journals, and excellent communication skills are encouraged to apply.
Please send a cover letter that includes why you are interested in this position, a curriculum vitae and names of three references by email in PDF format to:
Dr. Thomas Malek
Professor and Interim Chair
Department of Microbiology and Immunology
University of Miami Miller School of Medicine
UHealth-University of Miami Health System, South Florida’s only university-based health system, provides leading-edge patient care powered by the ground breaking research and medical education at the Miller School of Medicine. As an academic medical center, we are proud to serve South Florida, Latin America and the Caribbean. Our physicians represent more than 100 specialties and sub-specialties, and have more than one million patient encounters each year. Our tradition of excellence has earned worldwide recognition for outstanding teaching, research and patient care. We’re the challenge you’ve been looking for.
Patient safety is a top priority. As a result, during the Influenza (“the flu”) season (September through April), the University of Miami School of Medicine requires all employees who provide ongoing services to patients, work in a location (all Hospitals and clinics) where patient care is provided, or work in patient care or clinical care areas, to have an annu al influenza vaccination. Failure to meet this requirement will result in rescinding or termination of employment.